ABCM | Abcam plc

Index- P/E- EPS (ttm)-0.05 Insider Own6.55% Shs Outstand228.80M Perf Week3.62%
Market Cap3.47B Forward P/E- EPS next Y- Insider Trans0.00% Shs Float214.54M Perf Month-3.70%
Income-10.60M PEG- EPS next Q- Inst Own14.40% Short Float / Ratio0.28% / 0.75 Perf Quarter9.81%
Sales453.00M P/S7.67 EPS this Y-148.90% Inst Trans15.09% Short Interest0.60M Perf Half Y5.36%
Book/sh3.98 P/B4.25 EPS next Y- ROA-0.90% Target Price19.92 Perf Year13.42%
Cash/sh0.54 P/C31.14 EPS next 5Y0.39% ROE-1.20% 52W Range12.48 - 18.38 Perf YTD8.61%
Dividend- P/FCF- EPS past 5Y- ROI-0.30% 52W High-8.05% Beta-
Dividend %- Quick Ratio0.90 Sales past 5Y- Gross Margin74.80% 52W Low35.42% ATR0.70
Employees1800 Current Ratio1.30 Sales Q/Q19.70% Oper. Margin-2.80% RSI (14)56.00 Volatility3.96% 4.40%
OptionableYes Debt/Eq0.31 EPS Q/Q-207.00% Profit Margin-2.40% Rel Volume1.68 Prev Close16.25
ShortableYes LT Debt/Eq0.13 EarningsMar 20 BMO Payout- Avg Volume800.84K Price16.90
Recom2.30 SMA20-0.51% SMA508.82% SMA2009.70% Volume1,344,298 Change4.00%
Date Action Analyst Rating Change Price Target Change
Dec-14-22Initiated Deutsche Bank Hold $15
Nov-16-20Initiated Morgan Stanley Equal-Weight $21
May-30-23 04:30PM
May-23-23 09:55AM
May-17-23 09:18AM
May-11-23 11:45AM
04:30PM Loading…
May-04-23 04:30PM
May-01-23 06:00PM
Apr-17-23 07:00AM
Apr-13-23 04:15PM
Mar-30-23 07:00AM
Mar-20-23 07:05AM
Mar-10-23 08:00AM
Jan-30-23 08:00AM
Dec-27-22 04:58PM
Dec-12-22 09:53AM
03:20AM Loading…
Nov-16-22 05:09PM
Nov-11-22 10:30AM
Nov-09-22 06:00AM
Oct-17-22 02:00AM
Oct-05-22 09:25AM
Sep-13-22 04:24AM
Sep-12-22 08:00AM
Jul-20-22 09:50AM
Jul-13-22 01:22AM
Jun-27-22 02:00AM
Jun-18-22 04:24AM
05:35AM Loading…
May-02-22 05:35AM
Mar-25-22 08:40AM
Mar-18-22 10:00AM
Mar-14-22 08:00AM
Mar-10-22 04:46AM
Feb-01-22 04:00AM
Jan-09-22 01:02AM
Jan-04-22 04:00AM
Nov-09-21 11:16PM
Nov-02-21 08:00AM
Oct-27-21 02:00AM
Sep-13-21 07:00AM
Aug-02-21 07:38AM
Jul-29-21 09:06AM
Jul-13-21 12:44PM
Jun-24-21 08:09PM
Jun-22-21 08:00AM
May-29-21 06:33AM
May-24-21 02:59AM
Apr-12-21 05:00AM
Mar-24-21 07:49AM
Mar-08-21 11:15AM
Mar-04-21 04:00AM
Feb-26-21 02:00AM
Feb-17-21 07:00AM
Jan-28-21 07:08PM
Jan-27-21 08:00AM
Jan-11-21 07:00AM
Dec-08-20 07:00AM
Dec-05-20 08:03PM
Nov-03-20 08:35AM
Oct-26-20 11:45AM
Abcam plc, a life science company, focuses on identifying, developing, and distributing reagents and tools for scientific research, diagnostics, and drug discovery. The company's principal products include primary and secondary antibodies; conjugated antibodies and conjugation kits; singleplex immunoassays; proteins and peptides that include cytokines; edited cell lines and lysates; and various other products, including cellular activity kits, biochemicals, and cell signaling pathway tools. It serves scientists and researchers in academic institutions and research institutes, as well as in pharmaceutical, biotechnology, and diagnostics companies. The company has operations in the Americas, Europe, the Middle East, Africa, China, Japan, and rest of the Asia Pacific. It sells its products online. The company was incorporated in 1998 and is headquartered in Cambridge, the United Kingdom.